We are live on ! Find out more
SLG

Stanley-Laman Group Portfolio holdings

AUM $814M
1-Year Est. Return 40.24%
This Fund
S&P 500
This Quarter Est. Return
+5.61%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$375M
AUM Growth
+$5.98M
Cap. Flow
-$10.7M
Cap. Flow %
-2.85%
Top 10 Hldgs %
17.55%
Holding
221
New
23
Increased
111
Reduced
62
Closed
17

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$6.47M
2
ACAD icon
Acadia Pharmaceuticals
ACAD
+$4.68M
3
NBIX icon
Neurocrine Biosciences
NBIX
+$2.92M
4
CYBR
CyberArk
CYBR
+$2.32M
5
SANM icon
Sanmina
SANM
+$1.37M

Top Sells

Rank Stock Value
1
PANW icon
Palo Alto Networks
PANW
+$10.2M
2
INGR icon
Ingredion
INGR
+$8.28M
3
MDU icon
MDU Resources
MDU
+$8.08M
4
DIS icon
Walt Disney
DIS
+$6.24M
5
SUPN icon
Supernus Pharmaceuticals
SUPN
+$5.34M

Sector Composition

Rank Sector Weight
1 Healthcare 17.78%
2 Technology 15.38%
3 Industrials 12.46%
4 Consumer Staples 9.28%
5 Materials 8.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HOLX
26
DELISTED
Hologic
HOLX
$4.41M 1.18%
120,093
+14,284
+13% +$577K
BERY
27
DELISTED
Berry Global Group, Inc.
BERY
$4.39M 1.17%
84,327
+5,332
+7% +$279K
SEE
28
DELISTED
Sealed Air
SEE
$4.31M 1.15%
100,808
+9,666
+11% +$428K
FSS icon
29
Federal Signal
FSS
$7.19B
$4.2M 1.12%
197,427
+12,871
+7% +$241K
CAMP
30
DELISTED
CalAmp Corp.
CAMP
$4.13M 1.1%
7,727
+646
+9% +$285K
CRS icon
31
Carpenter Technology
CRS
$29.9B
$4.08M 1.09%
84,931
+11,904
+16% +$477K
UHS icon
32
Universal Health Services
UHS
$9.16B
$3.99M 1.06%
35,944
+3,987
+12% +$449K
LPNT
33
DELISTED
LifePoint Health, Inc.
LPNT
$3.96M 1.06%
68,381
+8,793
+15% +$523K
WCC
34
WESCO International
WCC
$16.1B
$3.55M 0.95%
60,927
+9,316
+18% +$501K
PFE icon
35
Pfizer
PFE
$143B
$3.54M 0.95%
104,532
-15,923
-13% -$512K
NBIX icon
36
Neurocrine Biosciences
NBIX
$17.5B
$3.4M 0.91%
+55,423
New +$2.92M
IDTI
37
DELISTED
Integrated Device Technology I
IDTI
$3.36M 0.9%
126,349
+18,941
+18% +$481K
PBH icon
38
Prestige Consumer Healthcare
PBH
$2.32B
$3.28M 0.88%
65,499
+7,394
+13% +$378K
CVS icon
39
CVS Health
CVS
$136B
$3.11M 0.83%
38,296
-4,993
-12% -$395K
CSCO icon
40
Cisco
CSCO
$444B
$2.97M 0.79%
88,249
+963
+1% +$30.7K
VZ icon
41
Verizon
VZ
$183B
$2.94M 0.79%
59,431
-8,216
-12% -$387K
KS
42
DELISTED
KapStone Paper and Pack Corp.
KS
$2.9M 0.77%
135,000
– –
CNA icon
43
CNA Financial
CNA
$14.1B
$2.88M 0.77%
57,315
-1,115
-2% -$55.8K
GILD icon
44
Gilead Sciences
GILD
$162B
$2.81M 0.75%
34,739
-5,051
-13% -$386K
T icon
45
AT&T
T
$160B
$2.72M 0.73%
91,883
-4,957
-5% -$141K
EXC icon
46
Exelon
EXC
$48.4B
$2.68M 0.71%
99,618
-5,468
-5% -$146K
TFC icon
47
Truist Financial
TFC
$62.5B
$2.64M 0.71%
56,310
-3,413
-6% -$157K
PG icon
48
Procter & Gamble
PG
$342B
$2.63M 0.7%
28,915
-1,272
-4% -$116K
MO icon
49
Altria Group
MO
$120B
$2.56M 0.68%
40,382
-843
-2% -$56.2K
KO icon
50
Coca-Cola
KO
$349B
$2.53M 0.68%
56,193
-2,216
-4% -$101K
1
2
3 4 5

Similar funds

VFG
Victory Financial Group Austin, Texas $814M AUM 18.17% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
CICI
Capital Investment Counsel Inc Raleigh, North Carolina $816M AUM 34.73% 1-Year Est. Return
UAG
United Advisor Group Cincinnati, Ohio $811M AUM 18.32% 1-Year Est. Return
PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
BC
Brio Consultants San Francisco, California $818M AUM 13.48% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

Stanley-Laman Group's Q3 2017 Portfolio in Review

As of Q3 2017, Stanley-Laman Group held 221 positions worth $375M, up 1.6% from $369M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Stanley-Laman Group's Q3 2017 filing shows 23 new, 111 increased, 62 reduced and 17 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 73,226 shares worth $6.82M. The largest sale was Palo Alto Networks, an estimated $10.2M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 15% a quarter earlier, followed by Technology and Industrials.

  • Stanley-Laman Group's largest Q3 2017 buy was BioMarin Pharmaceuticals: 73,226 shares worth $6.82M.
  • Stanley-Laman Group added most to Zix Corporation in Q3 2017, an estimated $1.31M increase.
  • Stanley-Laman Group's biggest Q3 2017 reduction was Palo Alto Networks, cutting an estimated $10.2M.
  • Stanley-Laman Group fully exited Supernus Pharmaceuticals in Q3 2017, selling an estimated $5.34M.
  • Stanley-Laman Group's ten largest holdings make up 18% of its $375M portfolio in Q3 2017.
  • Stanley-Laman Group opened 23 new positions and closed 17 in Q3 2017.
  • Stanley-Laman Group's portfolio value rose 1.6% quarter-over-quarter to $375M.

Based on Stanley-Laman Group's 13F filing for Q3 2017, filed 13 Nov 2017.